Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Syndax Pharmaceuticals, Inc. related to self-dealing, which may entitle shareholders to damages and corporate governance reforms [1]. Group 1 - Kuehn Law is a shareholder litigation law firm conducting an investigation into Syndax Pharmaceuticals, Inc. for possible self-dealing by its officers and directors [1]. - The investigation may lead to shareholders being entitled to damages and reforms in corporate governance [1]. - Long-term shareholders of Syndax Pharmaceuticals are encouraged to contact Kuehn Law for a free consultation regarding their rights [2]. Group 2 - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [3]. - Kuehn Law offers to cover all case costs and does not charge its investor clients, highlighting a no-obligation consultation [2]. - The firm encourages immediate contact from shareholders due to potential time limitations in enforcing their rights [2].